Package 59726-065-30

{"route": ["ORAL"], "spl_id": "008ee85b-5cac-45a6-a857-a828f8125175", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0359726443012"], "unii": ["R16CO5Y76E"], "rxcui": ["308416"], "spl_set_id": ["0058175f-3474-40c3-a046-6cfaec86d84b"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["P & L Development, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "300 TABLET, COATED in 1 BOTTLE, PLASTIC (59726-065-30)", "package_ndc": "59726-065-30", "marketing_start_date": "20210813"}], "brand_name": "Low Dose Aspirin", "product_id": "59726-065_008ee85b-5cac-45a6-a857-a828f8125175", "dosage_form": "TABLET, COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "59726-065", "generic_name": "Aspirin", "labeler_name": "P & L Development, LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Low Dose Aspirin", "active_ingredients": [{"name": "ASPIRIN", "strength": "81 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210813", "listing_expiration_date": "20261231"}